NKG2D controls natural reactivity of Vγ9Vδ2 T lymphocytes against mesenchymal glioblastoma cells - Archive ouverte HAL Access content directly
Journal Articles Clinical Cancer Research Year : 2019

NKG2D controls natural reactivity of Vγ9Vδ2 T lymphocytes against mesenchymal glioblastoma cells

(1, 2) , (3, 2) , (3, 2) , (3, 2) , (3, 2) , (3, 4) , (3) , (1) , (5) , (3, 2) , (3, 2) , (1, 2, 6) , (3, 2) , (3, 2) , (5, 2)
1
2
3
4
5
6

Abstract

PURPOSE: Cellular immunotherapies are currently being explored to eliminate highly invasive and chemoradioresistant glioblastoma (GBM) cells involved in rapid relapse. We recently showed that concomitant stereotactic injections of non-alloreactive allogeneic Vγ9Vδ2 T lymphocytes eradicate zoledronate-primed human GBM cells. In the present study, we investigated the spontaneous reactivity of allogeneic human Vγ9Vδ2 T lymphocytes toward primary human GBM cells, in vitro and in vivo, in absence of any prior sensitization. EXPERIMENTAL DESIGN: Through functional and trancriptomic analyses, we extensively characterized the immunoreactivity of human Vγ9Vδ2 T lymphocytes against various primary GBM cultures directly derived from patient tumors. RESULTS: We evidence that GBM cells displaying a mesenchymal subtype signature are spontaneously eliminated by allogeneic human Vγ9Vδ2 T lymphocytes, a reactivity process being mediated by γδ TCR and tightly regulated by cellular stress-associated NKG2D pathway. This led to the identification of highly-reactive Vγ9Vδ2 T lymphocyte populations, independently of a specific TCR repertoire signature. Moreover, we finally provide evidence of immunotherapeutic efficacy in vivo, in absence of any prior tumor cell sensitization. CONCLUSIONS: By identifying pathways implicated in the selective natural recognition of mesenchymal GBM cell subtypes, accounting for 30% of primary diagnosed and 60% of recurrent GBM, our results pave the way for novel targeted cellular immunotherapies. Copyright ©2019, American Association for Cancer Research.
Embargoed file
Embargoed file
Ne sera jamais visible
Loading...

Dates and versions

inserm-02316604 , version 1 (15-10-2019)

Identifiers

Cite

Cynthia Chauvin, Noémie Joalland, Jeanne Perroteau, Ulrich Jarry, Laura Lafrance, et al.. NKG2D controls natural reactivity of Vγ9Vδ2 T lymphocytes against mesenchymal glioblastoma cells: Vγ9Vδ2 T lymphocytes react against mesenchymal glioblastoma. Clinical Cancer Research, In press, clincanres.0375.2019 (Epub ahead of print). ⟨10.1158/1078-0432.CCR-19-0375⟩. ⟨inserm-02316604⟩
58 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More